Precigen $129 million common stock offering
We advised the underwriters in connection with the SEC-registered equity offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Primavera Capital Acquisition $414 million IPO
We advised Primavera, a SPAC, on its IPO and NYSE listing
Silvergate Capital $287.5 million follow-on offering
We advised the underwriters in connection with the equity offering
BJ’s Restaurants $30 million SEC-registered at-the-market offering
We advised the sales agent in connection with the equity offering
Cryoport $287.5 million follow-on offering
We advised the underwriters on the SEC-registered offering
CytomX Therapeutics $100 million follow-on offering
We advised the joint book-running managers in connection with the equity offering
Dream Finders Homes $143.5 million IPO
We advised the underwriters in connection with the IPO and Nasdaq listing
Editas Medicine $231 million stock offering
We advised the joint book-running managers in connection with the equity offering
Innovent Biologics HK$4.73 billion placement of shares
We advised the joint placing agents in connection with the equity offering
Morgan Stanley $7.5 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering